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Abstract For detection of the plant pathogenic Tulip
virus X (TuVX), a panel of six recombinant antibodies
was identified. To this end, a repertoire of variable
domains from heavy-chain immunoglobulins (VHH)
was cloned from an alpaca, which had been immu-
nized with TuVX. Binding domains were selected by
phage display and panning on immobilized TuVX
particles. Recombinant VHH antibodies were tested
for sensitivity in a sandwich ELISA, and were
demonstrated to be readily able to distinguish
TuVX-infected tulip leaf material from uninfected
leafs. No cross-reactivity of the VHH antibodies to
related flexiviridae was observed. Recombinant
VHHs maintained their reactivity upon storage at
−20°C for over a year. The effect of incubation at
higher temperatures for prolonged time was studied.
Two out of three VHH proteins retained activity after
several weeks of storage at 37°C.
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Abbreviations
CDR complementarity-determining region
scFv single-chain variable fragment
VHH variable domains from heavy-chain
immunoglobulin
TuVX Tulip virus X
PVS Potato virus S
PVX Potato virus X
PepMV Pepino mosaic virus
KMV Kalanchoe mosaic virus
CVB Chrysanthemum virus B
Introduction
Antibodies have a long history of application in the
detection of plant pathogens. They are key elements
in routine immunological tests, due to their low price,
high specificity and reliable and fast performance. For
this reason, immunoassays are essential to test the
phytosanitary status of large volumes of plant
material. For example, for the trade of tulip material,
1.7 million extractions for virus analysis are per-
formed in The Netherlands annually.
Immunological tests for detection of plant patho-
genic viruses usually involve the use of antiserum,
raised in rabbit, chicken or mouse. Since the
characteristics of these antisera differ between indi-
vidual animals, their application in certified tests
requires exhaustive tests for every new batch pro-
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duced. For this reason, monoclonal antibodies
obtained by hybridoma technology, or recombinant
antibodies expressed in micro-organisms have been
considered as an alternative. Over the past 15 years,
selection of recombinant monoclonal antibodies by
phage display has been developed (Hoogenboom
2005). This involves construction of libraries of
antibody fragments, expressed on the surface of
bacteriophages, and selection of desired antibody
fragments from the library. In most cases, the frag-
ments consist of single-chain variable fragments
(scFvs), which are fusions of the variable domains
of antibody heavy and light chains through a flexible
synthetic linker. Recombinant scFvs have mainly
been applied in the medical research field, but have
also been described for a number of plant viruses
(reviewed in Ziegler and Torrance 2002) and a few
other plant pathogens (Griep et al. 1998). However, a
large scale transition of plant pathogen detection from
classical antisera to recombinant antibodies (such as
scFvs) has not been made.
Solubility and stability are an important issue for
recombinant antibodies. Though a number of studies
report on high accumulation of soluble recombinant
antibody fragments like scFv, others describe poor
solubility and a propensity to irreversibly aggregate
(Moss et al. 2003; Hamilton et al. 2003; Holliger and
Hudson 2005). In recent years, antibody sources have
been explored that give rise to soluble recombinant
antibodies with a higher frequency. Among those are
heavy-chain IgG antibodies from camelids, such as
camels, dromedaries and llamas (Ghahroudi et al.
1997). Remarkably, camelid heavy-chain IgGs do not
involve a light-chain, and lack the first constant
domain of the heavy chain, which is replaced by an
exceptionally long hinge region (Hamers-Casterman
et al. 1993). The variable part of these antibodies
(referred to as the VHH domain) is a single
immunoglobulin-folded protein domain of about 140
amino acids, which does not involve artificial linkers.
Generally, VHH domains can be produced in large
quantities in microbial recombinant systems as stable,
water-soluble molecules (Ghahroudi et al. 1997;
Muyldermans 2001).
In this study, Tulip virus X (TuVX) was applied as
an example of a plant pathogen for development of
novel immunological detection tools. TuVX is among
the more abundant pathogens for tulip. It is a
filamentous, positive-stranded RNA virus, belonging
to the family of flexiviridae and the genus of potex
viruses. Its natural hosts are Tulipa species. Symptoms
of infection comprise chlorotic or necrotic grey–brown
streaking of leaves and streaks of intensified pigment
(or of necrosis) in petals (ICTVdB-Management 2006).
The amount of TuVX tests (currently 7,000 per year in
The Netherlands) is expected to increase, firstly
because infection incidence seems to be increasing,
and secondly, because an increasing number of
countries impose a quarantine status on this virus.
TuVX is considered by several governments as a
pathogen of potential quarantine concern on flower
bulb imports. Therefore we set out to isolate recom-
binant antibodies for detection of TuVX from an
immunized alpaca for standardized application.
Materials and methods
Library construction and panning
A VHH library was created from lymphocyte RNA
from alpaca which had been immunized with TuVX
particles. A 3-year old female alpaca (ID-Lelystad,
The Netherlands) was immunized with 100 μg of
purified virus material (supplied by PPO Lisse, The
Netherlands, purified from tulip material), suspended
in Stimune (Cedi diagnostics, Lelystad), according to
institutional guidelines. After 4 and 8 weeks, the
immunization was repeated. After 5 and 9 weeks,
150 ml blood was drawn from the neck vein and
immediately mixed with heparin. Peripheral lympho-
cytes were purified using a Ficoll gradient, and total
RNA was purified using the RNAeasy kit (Qiagen,
The Netherlands). For each RNA sample, cDNA was
generated using random hexamers. VHH fragments
were amplified from first-strand cDNA with VHH
specific primers (De Haard et al. 2002). Amplified
fragments were pooled and ligated into the pCAN-
TAB-5E vector (Pharmacia) in frame with the M13
gene 3 for expression of VHH-g3p fusion protein.
Recombinant plasmids were introduced into compe-
tent Escherichia coli TG1 cells by electroporation,
and about 107 individual recombinants were obtained
and pooled.
Phage particles were obtained by inoculating 109
library cells into 25 ml 2xYTmedium with 100 μg ml−1
ampicillin and 1% glucose growing at 37°C and
250 rpm. After the culture had reached a density of
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±2.4×108 cells ml−1, it was infected with helper
phage VCSM13 for 1 h and then centrifuged. The
bacterial pellet was resuspended in YT medium with
100 μg ml−1 ampicillin and 50 μg ml−1 kanamycin
for the production of phages, and further incubated
overnight at 30°C and 250 rpm. Particles were
harvested by PEG-precipitation.
The phage displayed VHH antibodies were panned
against four different concentrations (0.4, 2, 10, and
25 μg ml−1) of TuVX particles coated in ELISA
plates. Phages binding to the TuVX coating were
eluted with trypsin and used to infect four batches of
4.8×108 E. coli TG1 cells. The four batches of cells
were plated separately on solid LB medium with 1%
glucose and 100 μg ml−1 ampicillin and the obtained
colonies were pooled. To further enrich for TuVX-
positive antibodies the panning procedure was repeat-
ed twice.
Recloning of selected VHH fragments for expression
After enrichment by three rounds of panning against
TuVX, pooled phages were used to infect E. coli
TG1. Phagemid DNAwas isolated from 4×107 E. coli
cells. The VHH inserts were amplified by PCR to add
the appropriate restriction sites, digested with NdeI
and SfiI at the primer ends and ligated into the
CM194 expression vector (CatchMabs, The Nether-
lands), a derivative of pET12a (Novagen). Expression
of the VHH recombinant antibody is under control of
the T7 promoter. The C-terminus of the VHH
fragment is fused to a VSV-G tag (YTDIEMNRLGK)
for detection purposes, followed by a C-terminal 6×
His tag for purification.
For expression, plasmids were introduced into E.
coli BL21-AI. This strain carries a chromosomal
insertion of the gene encoding T7 RNA polymerase
in the araB locus of the araBAD operon, allowing
expression of the recombinant VHH antibody in the
presence of L-arabinose. Inserts of 28 randomly
picked colonies were amplified and subjected to
sequence analysis.
Expression and purification of recombinant VHH
antibodies
For expression, 200 ml of 2xYT medium containing
100 μg ml−1 of ampicillin was inoculated with an
overnight culture of BL21-AI carrying the VHH
expression plasmids. Cultures were grown to an
OD600 of 0.6–0.8 at 37°C at 250 rpm. Subsequently
expression of the antibodies was induced by adding
0.02% L-arabinose, and continued by incubation of
the culture for 4 h at 37°C at 250 rpm. Bacteria were
harvested by centrifugation and the pellet was
resuspended in 20 ml of 9M urea in PBS and
incubated for 30 min at room temperature to allow
cell lysis and solubilization of intracellular inclusion
bodies. The cell lysate was centrifuged at 15,500 RCF
for 2 h at 4°C. The clarified supernatant was diluted
with 180 ml 50 mM Tris–HCl pH 9 with 150 mM
NaCl (TN buffer) and incubated for 1 h to allow
refolding of the antibodies. The material was subse-
quently centrifuged at 15,500 RCF for 2 h at 4°C and
the supernatant was used to purify the recombinant 6×
His tagged VHH antibodies with Ni-NTA metal-
affinity chromatography.
For purification, the clarified cell lysate including
the refolded VHH antibodies was brought to a final
concentration of 10 mM imidazole and incubated for
1 h with 2.5 ml of Ni-NTA resin (Qiagen) pre-
equilibrated with TN buffer. The resin mixture was
loaded into a column, drained and subsequently
washed with 50 ml of TN buffer containing 20 mM
imidazole and finally proteins were eluted with 25 ml
of TN buffer containing 250 mM imidazole.
The eluate was dialyzed against 5 l of TN buffer in
three steps, to remove imidazole, and stored in 2 ml
batches at −20°C.
Antigen-coated plate ELISA
Wells of a 96-well microtitre plate (Greiner, The
Netherlands) were coated for 2 h at 27°C with 100 μl
of TuVX, helper phage VCS-M13, Potato virus S
(PVS; isolate IJsselster), Potato virus X (PVX; isolate
PVX3), Pepino mosaic virus (PepMV; isolate P1),
Kalanchoe mosaic virus (KMV; isolate Kal6), or
Chrysanthemum virus B (CVB; isolate RR). TuVX
was diluted to 2 μg ml−1 in sodium carbonate buffer
(0.1 M, pH 9.6). All other virus stocks were of
unknown concentration as they were isolated with a
background of nucleic acids from plants. The extracts
were known to be suitable for immunological detec-
tion proved by regular testing with conventional
polyclonal antiserum (Prime Diagnostics). The virus
stocks were diluted five-fold in 0.1 M sodium
carbonate buffer pH 9.6. After virus coating, wells
Eur J Plant Pathol (2008) 121:477–485 479
were washed once with 200 μl of TN-buffer and
blocked with 150 μl of TNE buffer (2% non-fat dried
milk powder in TN buffer) for 1 h at 27°C. Further
steps were carried out at room temperature. Wells
were emptied and incubated for 1 h with 100 μl of
recombinant VHH antibody (5 μg ml−1 in TNE
buffer). After washing three times with 200 μl of
TNT buffer (TN buffer containing 0.05% Tween-20),
wells were incubated for 60 min with 100 μl of
monoclonal Anti-VSV-G peroxidase conjugate (Sig-
ma) diluted 1:2,000 in TNE buffer. Wells were
emptied and washed three times with 200 μl of TNT
buffer followed by washing three times with 200 μl of
TN buffer. 100 μl of TMB substrate solution (Pierce)
was added per well and incubated for 30 min
maximum in the dark. To stop the reaction, 50 μl of
2 N sulphuric acid was added to each well, after
which the absorbance was measured at 415 nm in a
microplate reader (EL808, Bio-Tek Instruments Inc.,
The Netherlands). The data were analyzed using the
software linked to the microplate reader (KC4,
KinetiCalc version 3.3 ref 10 for Windows XP, Bio-
Tek Instruments Inc. Titertek, The Netherlands).
DAS-ELISA
Wells of a 96-well microtitre plate (Greiner) were
coated overnight at 4°C with 100 μl of polyclonal
rabbit anti TuVX gamma-immunoglobulin (serum
obtained from PPO, Lisse) (2 μg ml−1 in sodium
carbonate buffer, pH 9.6). Subsequent steps were
carried out at room temperature. Wells were washed
once with 200 μl TN buffer and blocked with 150 μl
TNE buffer for 90 min. Wells were emptied, 100 μl
either healthy, naturally infected or spiked leaf extract
diluted 1:10 and 1:100 in 2% TNE buffer was added.
The spiked leaf extract contained a dilution series of
TuVX (16, 8, 4, 2, 1, 0.5, 0.25 or 0 μg ml−1). The
plate was incubated for 60 min at room temperature,
after which the wells were emptied, washed three
times with 200 μl TNT buffer and incubated for 1 h
with 100 μl diluted VHH 5 μg ml−1 in TNE buffer.
Detection proceeded in the same way as described
above for the direct ELISA procedure.
For storage experiments the VHH antibody stocks
were divided into four portions, and stored at either
−20, 4, 21 or 37°C. Sodium azide (0.5%) was added
to prevent microbial contamination. The stocks were
diluted to 0.05 μg ml−1 in TNE buffer; otherwise the
assay was carried out as described above.
Results
Recombinant antibodies recognizing TuVX
Recombinant antibodies for detection of TuVX were
obtained from alpaca. As a first step, a female alpaca
was immunized and boosted twice with 100 μg
purified TuVX particles. A VHH library was created
from lymphocyte RNA from this animal, and the
library was subjected to three rounds of panning on
TuVX material. After the last panning, VHH inserts
were mass-excised and transferred into an expression
vector where the C-terminus of the encoded VHH
domain is fused to a VSV-tag, followed by a C-
terminal His-6 tag.
The DNA sequences of 28 selected VHHs were
analyzed. The resulting sequences have been depos-
ited to Genbank (accession numbers EF455532 to
EF455558). The deduced protein sequences are
shown in Fig. 1. Variation is mainly confined to the
complementarity-determining regions (CDRs), which
are involved in the binding of the antigen. Among the
28 analyzed sequences, five sequence groups could be
distinguished by variations in the CDR regions.
Group 1 (TVX72, 78, 94, 88, 71, 82, 91, 86 and 81)
is distinguished by its CDR3 sequence (NANWGATN).
Group 2 (TVX84 and 76), group 3 (TVX92) and
group 4 (TVX73, 89, 90, 85, 93, 87, 74 and 79)
have comparable CDR1 and CDR2 regions to group
1, but differ in their CDR3 region. The CDR3
region of group 4 is clearly extended, having five to
eight residues more than the other groups. The
feature of an extended CDR3 region is considered to
be typical for camelid antibodies. Group 5 (TVX80,
83, 69, 75, 95, 96, 70 and 77) is clearly distin-
guished from the other groups by its CDR3 region,
but also by its completely different CDR1 and
CDR2 regions, where the CDR2 region is three
residues larger in size than in the other groups. This
indicated that, in contrast to unselected VHH clones
(not shown) clusters of VHH domains can be
distinguished in the TuVX-selected population.
The selected VHH molecules all belong to the
same subfamily of camelid antibodies. Four distinct
subfamilies in llama heavy-chain VHH domains have
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been distinguished (Harmsen et al. 2000). These
subfamilies are defined by the incidence of a number
of key-residues in the VHH amino-acid sequence.
Typically the anti-TuVX VHH sequences have sub-
family 2 features, such as the Y residue at position 38,
the number of residues in CDR2 (seven instead of
typically eight), the N at positions 62 and 100. None
of the CDR1 and CDR3 regions contains any
additional cystein residues, which only occur in
subfamilies 3 and 4. Remarkably, the residue at
position 48 in all anti-TuVX VHH sequences is a V,
while this position has a strong preference for F
(subfamily 1) or L (subfamily 2), and V is found only
in one out of 152 VHH sequences described by
Harmsen et al. (2000).
Most selected VHH molecules could easily be
purified in significant quantities. For each sequence
group, a representative clone was selected for further
analysis. Clone TVX69 (group 5) displayed a contin-
uous tendency to precipitate during purification, while
all others tested remained soluble. Three VHH
domains (TVX90, TVX92 and TVX76) were
expressed in 200 ml cultures and purified from
inclusion bodies by Ni-affinity chromatography. As
exemplified in Fig. 2, the expressed proteins were the
dominant protein in the E. coli cell pellet (Lane A),
and Ni-affinity purification removed most of the other
proteins (Lane E). The yields of purified recombinant
proteins TVX76, TVX90 and TVX92 were 4.2, 6.4
and 5.4 mg per 200 ml culture, respectively.
Antibody specificity
Antibodies were tested by ELISA using the VSV-tag
for detection. Firstly, reactivity to TuVX particles
which had been directly immobilized on ELISA wells
was assessed, and compared to reactivity to bacterio-
Fig. 2 Protein purification. Shown is a 15% SDS PAGE gel,
stained by Coomassie BB. Indicated are the positions of
relevant size markers in kDa. Lane A: Total culture of
TVX72. Lane B: Soluble protein, after cell lysis and refolding.
Lane C: Flow-through of the Ni-NTA column; Lane D: Eluted
protein from the Ni-NTA column; Lane E: TVX72 after
dialysis, as it is stored and applied in the tests
CDR1 CDR2                                CDR3                      VSV     His-6
10        20        30     40        50        60        70        80        90        100      110       120       130       140       150   
|         |         |         |         |         |         |         |         |         |         |         |         |         |         |  
TVX72 MQVQLQESGGGLVQPGGSLRLSCAAPGLTFSIYLMGWYRQAPGKQREVVARIG---SGGYTNYADSVKGRFTISRDNAKNTVDLQMNSLKPEDTAVYYCNAN--WGATN-----HWGKGTQVTVSSASSAGGGGSYTDIEMNRLGKSHHHHHHG
TVX78 .................................F...................---..............................................--.....-----........................................
TVX94 ..............................R......................---..............................................--.....-----...Q....................................
TVX88 ..............................R......................---..............................................--.....-----F..Q....................................
TVX71 ..............................R......................---..............................................--.....-----F.....L.................................
TVX82 ..............................R......................---..............................................--.....-----F.....L.................................
TVX91 ..............................R......................---..............................................--.....-----F....IL.................................
TVX96 ..............................R......................---..............................................--.....-----F..Q..L.................................
TVX81 .........................S....R..R.S..............F.T---........E.....L...........A...................--.....-----F..Q..L.................................
TVX84 .........................S....R..R.....R..........F.T---.......V..................S....R.NA......S...RNP.SSE.-----Y.....K.................................
TVX76 .........................S.F...T.S.R..............Y.N---...I....T.................F........D.........LWP..TE.-----Y..Q..L.................................
TVX92 .........................S.F...T.A.S...............YS---...I........A.............Y................Y.KNV.TN..-----Y.....L.................................
TVX73 .........................S.......R.S..............F.T---.......VE.....L...........A...S...............NP.KTA.GGPNNY........A..............................
TVX89 .........................S.......R.S..............F.T---.......VE.....L...........A...S..............VNP.KTA.GGPANY.......................................
TVX90 .........................S.......R.S..............F.T---.......VE.................A...S...............NP.KTA.DGPNNY.......................................
TVX85 .........................S.......R.S..............F.T---.......VE.....L........S..S...S...............NP.KTA.DGPSSY..Q..L.................................
TVX93 .........................S.......R.S..............F.T---.......VEP....L...........S...S...............NP.KTA.DGPSNY....IL.................................
TVX87 .........................S.......R.S..............F.T---.......VE.....L...........A.R.S...............NP.KTA.DGPNNY..Q..L.................................
TVX74 .........................S.......R................F.T---.......I..................S...S..............VNP.KTA.GGPSNY..Q.I..................................
TVX79 .............R.....G.....S.......R................F.T---.......I..................S...S..............VNP.KTA.GGPSNY.....L.................................
TVX80 .........................S.TILQFAP..........L.....S.AGIY..E..G....................Y.................K.P--V.W.------.......................................
TVX83 .........................S.TILQFAP..........L.....S.AGIY..E..G....................Y.................L.P--V.W.------..Q....................................
TVX69 ................R........S.TILQFAP..........L.....S.AGIY..E..G....................Y...S.............L.P--VQW.------.......................................
TVX75 .........................S.TILQFAP................S.AGIY..A..T.V.............P....Y....G............K.P--V.W.------..Q....................................
TVX95 .........................S.TILQFAP................S.AGIY..A..T.V.............P....Y.................L.P--V.WK------.........L.............................
TVX96 .........................S.TILQFAP..........L.....S.AGIY..E..T.V....C.............Y..........A......K.P--V.W.------..Q..L.................................
TVX70 .........................S.TILQFAP................S.TGIH...N.................P....Y.................L.P--VQW.------..Q..L.................................
TVX77 .........................S.TILQFAS................S.TGIH...N......................Y............A....L.P--V.WK------.......................................
Fig. 1 Alignment of protein sequences from selected VHHs.
Only amino-acid residues at positions differing from the top
sequence (TVX72) have been indicated. Dots indicate identity
to the top sequence, dashes indicate absence of amino-acid
residues, compared to the top sequence
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phage VCSM13 as a control. VCSM13 particles are
also filamentous, but otherwise unrelated to TuVX.
All three tested clones reacted equally well with
TuVX, and did not produce a signal with VCSM13
(Table 1). This indicated that the selected antibodies
could recognize TuVX.
The specificity of TVX76, TVX90 and TVX92
was further investigated using a number of flexivir-
idae. For this purpose, the potex viruses Potato virus
S (PVS), Potato virus X (PVX), Kalanchoe mosaic
virus (KMV) and Pepino mosaic virus (PepMV), and
the carlavirus Chrysanthemum virus B (CVB) were
compared to TuVX in an ELISA experiment where
the virus material was directly coated in the ELISA
plate wells. In all experiments, signals did not exceed
those of the buffer (carbonate buffer) or uninfected
plant material (Table 1), in contrast to the TuVX
material. Thus, it appeared that the antibodies are
specific for TuVX, though it cannot be excluded that
the direct coating interfered with the integrity of the
other potex and carla viruses.
DAS-ELISAs
Application of plant pathogen antibodies routinely
includes double antibody sandwich ELISA tests
(DAS-ELISA). The activity of TVX76 in particular
was further tested using a DAS-ELISA. As capture
probe, polyclonal rabbit anti TuVX serum was used.
Detection of virus material in different dilutions was
tested. Virus particles were tested in dilutions between
16 μg ml−1 and 0.25 μg ml−1, either in carbonate
buffer, 10-fold diluted tulip leaf extract or 100-fold
diluted tulip leaf extract. For all tested virus dilutions,
significant signals were observed. The background
signal (in the absence of virus particles) was less than
2% of the maximal signal, while 0.25 μg ml−1 virus
dilution gave a signal which was more than 10-fold
higher than the background (Fig. 3) The DAS-ELISA
system was further tested on leaf material from TuVX-
infected plants. The 1:10 and 1:100 fold diluted
infected plant material produced clearly positive
ELISA signals (arrows in Fig. 3). The detection limit
is comparable to that of other serological virus tests,
leading us to conclude that the TVX76 VHH allows
sensitive detection of TuVX in infected plant material.
Similar results were obtained for TVX90 and TVX92
(not shown, see below).
Storage
Camelid single chain antibody fragments are attrac-
tive for diagnostics because they are generally less
prone to precipitation and aggregation, as compared
to scFv antibody fragments (Holliger and Hudson
2005). To substantiate this further, purified antibodies
TVX90, TVX92 and TVX76 were tested in DAS-
ELISA for their resistance to prolonged storage at
different temperatures. For this purpose, antibodies
were diluted 100-fold more than in the above
described DAS-ELISA, to facilitate monitoring of
changes in detection efficiency. After initial testing,
antibody stocks of 0.1 μg ml−1 were stored at −20,
+4, 21 or 37°C for several weeks. No special
precautions were taken to enhance protein stability,
except that a low amount of azide was added to
prevent microbial contamination. At regular intervals,
antibodies were diluted to critical concentrations, and
DAS-ELISAs on a range of concentrations of TuVX
diluted in TNE buffer were performed.
The lowest concentration of virus at which a
threshold signal of four times the background (signal
in the absence of virus material) was observed
(Table 2), was determined. The reactivity of anti-
bodies TVX90 and TVX92 did not change upon
storage for 8 weeks at −20 or 4°C. In general, TVX76
was more sensitive to the temperature treatments. Its
reactivity was reduced after storage at 4°C, and it did
not resist storage of more than 1 week at room
temperature or 37°C. Antibody TVX92 on the other
hand was still highly reactive after 5 weeks of storage
at 37°C, and only after 8 weeks showed a clear
decrease in activity. Antibody TVX90 behaved
Table 1 Reactivity of recombinant VHHs to different viruses
TVX90 TVX92 TVX76 No antibody
TuVX 598±118a 603±74 575±4 6±1
KMV 6±1 5±2 11±10 6±1
CVB 10±1 9±0 9±1 9±1
PepMV 8±1 8±0 9±3 7±1
PVX 7±0 9±1 8±1 8±3
PVS 8±1 8±1 7±1 8±4
VCSM13 8±1 10±1 6±1 7±1
a Reactivity is expressed as ELISA signal (mU at 415 nm after
15 min). The value is the average of two independent
measurements.
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similarly to TVX92. Thus, two out of three antibodies
showed excellent behaviour during storage.
Discussion
Camelid VHH domains form a special class of
recombinant antibodies. VHH domains from camels,
dromedaries and llamas have been described (Harmsen
et al. 2000). In this paper, for the first time, the
isolation of recombinant antibodies from Alpaca is
described. Alpacas are part of the camelid family, and
are often classified as a subspecies of the llama.
However, recent DNA marker analyses have demon-
strated that, while the llama (Lama glama) has been
domesticated from guanacos, the alpaca is descended
from the vicuña, and should be classified as Vicugna
pacos (Kadwell et al. 2001). The selected alpaca
VHH domains show good sequence homology to the
known VHH domains from other camelids; for
instance the protein sequence of TVX72 is 80%
identical to that of a L. glama VHH domain
(accession CAD22462). In this study, an alpaca was
involved for acquiring VHH domains because of its
smaller size and generally tame behaviour. The
sequences shown in Fig. 1 thus represent the first
DAS ELISA TVX76
0
0.5
1
1.5
2
2.5
3
3.5
16 8 4 2 1 0.5 0.25 0
ug ml-1 TVX
EL
IS
A 
si
gn
al
1/10 leaf
1/100 leaf
NaCarb
Fig. 3 DAS-ELISA result for TVX76 with different virus
dilutions and infected plant material. Squares represent virus
particles suspended in a 1:10 diluted tulip leaf extract. Circles
represent virus particles suspended in 1:100 diluted tulip leaf
extract. Triangles represent virus particles suspended in
carbonate buffer. The values on the right (above the 0) are the
background levels of uninfected leaf material or carbonate
buffer. The solid arrow indicates the signal from a 1:10 diluted
extract from naturally infected tulip leaf material, while the
open arrow represents the signal of 1:100 diluted extract from
naturally infected tulip leaf material
Week 0 Week 1 Week 2 Week 5 Week 8
TVX90 −20°C 1a 1 0.5 1 1
4°C 1 1 0.5 1 2
20°C 1 2 0.5 1 10
37°C 1 1 0.5 2 >10
TVX92 −20°C 1 0.25 0.5 1 0.5
4°C 1 0.25 0.5 1 1
20°C 1 0.25 0.5 1 10
37°C 1 0.25 0.5 1 10
TVX76 −20°C 0.5 0.25 0.5 1 1
4°C 0.5 0.25 10 1 10
20°C 0.5 0.25 10 >10 >10
37°C 0.5 0.25 >10 >10 >10
Table 2 Storage behaviour
of recombinant VHHs
a Shown is the concentra-
tion of TuVX virus (in
μg ml−1 ) at which the sig-
nal is at least four times the
background.
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immunoglobulin sequence information for the Vicu-
gna family.
This also is the first report on recombinant
antibodies from camelid origin for phytosanitary
purposes. In this field, recombinant antibodies have
mainly been derived from human or mouse naïve
libraries (Ziegler and Torrance 2002), and concern
scFv antibody fragments. Though some have reported
successful application of these fragments, (Holliger
and Hudson 2005) note that the application of scFvs
has been severely hampered by their tendency to
precipitate, referring likely to numerous unpublished
disappointments in scFv proteins, including our own.
Poor solubility has for instance been reported for a
His-purified scFv for detection of cocaine, which
precipitated during 2 weeks of storage, irrespective of
the concentration, unless it was further purified and
lyophilized (Moss et al. 2003). Another His-purified
scFv for detection of melanoma-associated proteogly-
can was described to be only soluble to 150 μg ml−1
during storage at 4°C (Hamilton et al. 2003). For
comparison, all VHH stocks tested by us were stable
at 4°C in concentrations exceeding 0.5 mg ml−1, and
only one out of these six selected VHH domains
suffered from any precipitation.
Some clear advantages have been noted for camelid
VHH domains over scFv fragments, in particular
relating to robustness. For instance, VHH domains
have the ability to refold after melting (Ewert et al.
2002). A comparison has been made between VHH
antibody fragments and mouse monoclonal antibodies
(van der Linden et al. 1999). While most mouse
monoclonal antibodies retain hardly any reactivity
after 2 h incubation at 70°C, VHH fragments
preserved full binding even after 2 h incubations at
90°C. Binding capabilities of VHH domains and
soluble human VH3 domains have been compared
after temperature treatments (Ewert et al. 2002). It was
observed that the binding capacities of VHH domains
were almost fully recovered after heating to 80°C,
while soluble human VH3 fragments irreversibly
precipitate at temperatures higher than 65°C. Similar
observations have been made on a panel of VHHs for
detection of diverse antigens (Goldman et al. 2006).
In our study, we tested the storage behaviour of
TuVX-binding VHH domains, and observed that
activity is best maintained after storage at −20 or
+4°C, while two out of three tested VHH domains
resisted incubation at 37°C for 5 weeks. Though this
study does not include a comparison with monoclonal
antibodies or scFv molecules, this behaviour at least
parallels that of commonly used purified IgGs and
alkaline phosphatase-conjugated antibodies originat-
ing from rabbit. In our opinion, this represents a clear
benefit of the VHH over the scFv type of recombinant
antibodies, which, in our hands, remained very poorly
stable upon storage at −20°C, or transportation at
ambient temperature.
Immunological detection of plant pathogens is
predominantly performed with classical antisera
raised by immunization of rabbits. However, the
policy of governments is aimed to reduce animal
suffering and to require constant quality of the
performance of an assay. The use of recombinant
antibodies allows implementation of diagnostic sera
production in standard microbiological laboratories
according to ISO17025 certification. Facilities to
produce polyclonal sera are demanding to set-up or
maintain and are less robust in production capacity.
Diagnostics using immunochemistry is still under
constant innovation. Examples are the development of
easy-to-handle, field-compatible tests such as lateral-
flow (Delmulle et al. 2005), but also more complex
test set-ups like flow-cytometry (Chitarra et al. 2002),
and multiplex detection using Luminex (Rao et al.
2004; Peters et al. 2007) or protein chips (Taitt et al.
2004). Use of recombinant antibodies, fused to specific
tags, may facilitate multiplex design (Wingren and
Borrebaeck 2006). Such tags may comprise DNA
(Jongsma and Litjens 2006), His-stretches (Larsson et
al. 2005) or many other oligo-peptidic moieties. The
availability of recombinant antibodies facilitates the
development of such multiplex immunological assays.
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